Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

US Patent 12083227 · Granted Sep 10, 2024

Estimated economic value: $1,593,423,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-flu2025
Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycy2024
Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycy2024
Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-flu2022
High dosage valbenazine formulation and compositions, methods, and kits related 2022
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoq2022
High dosage valbenazine formulation and compositions, methods, and kits related 2021
Salts and crystalline forms of an apoptosis-inducing agent2020
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoq2020
Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoqu2018
Salts and crystalline forms of an apoptosis-inducing agent2017
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoq2017